Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Interference with KCTD9 inhibits NK cell activation and ameliorates fulminant liver failure in mice

Fig. 2

mKCTD9 shRNAs inhibited mKCTD9 expression in vitro. a Relative fold of mKCTD9 mRNA in CHO cell transfected with either shRNAs against mKCTD9, pcDNA3.1-mKCTD9, as well as scramble control. b inhibition efficiency or shRNAs against mKCTD9. c West bolt analysis of mKCTD9 expression in CHO cells transfected with pcDNA-mKCTD9, pMSCV-mKCTD9-shRNA1, pMSCV-mKCTD9-shRNA2, pMSCV-scramble shRNA (Negative Control as indicated in the figure); relative value of mKCTD9 protein levels were (from left to right): 2.25, 1.71, 1.0, 0.86, 0.96. **p < 0.01

Back to article page